These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9833920)

  • 1. Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNA.
    Ellouk-Achard S; Djenabi S; De Oliveira GA; Desauty G; Duc HT; Zohair M; Trojan J; Claude JR; Sarasin A; Lafarge-Frayssinet C
    J Hepatol; 1998 Nov; 29(5):807-18. PubMed ID: 9833920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression.
    Lafarge-Frayssinet C; Duc HT; Frayssinet C; Sarasin A; Anthony D; Guo Y; Trojan J
    Cancer Gene Ther; 1997; 4(5):276-85. PubMed ID: 9345599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in tumorigenicity of embryonal carcinoma cells by IGF-I triple-helix induced changes in immunogenicity and apoptosis.
    Ly A; Francois JC; Upegui-Gonzalez LC; Swiercz B; Bedel C; Duc HT; Bout D; Trojan J
    Life Sci; 2000 Dec; 68(3):307-19. PubMed ID: 11191646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.
    Ly A; Duc HT; Kalamarides M; Trojan LA; Pan Y; Shevelev A; François JC; Noël T; Kane A; Henin D; Anthony DD; Trojan J
    Mol Pathol; 2001 Aug; 54(4):230-9. PubMed ID: 11477137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of insulin-like growth factors-IR and -IIR antisense gene transfection on the biological behaviors of SMMC-7721 human hepatoma cells.
    Yang JM; Chen WS; Liu ZP; Luo YH; Liu WW
    J Gastroenterol Hepatol; 2003 Mar; 18(3):296-301. PubMed ID: 12603530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-I triple helix strategy in hepatoma treatment.
    Upegui-Gonzalez LC; Ly A; Sierzega M; Jarocki P; Trojan L; Duc HT; Pan Y; Shevelev A; Henin D; Anthony D; Nowak W; Popiela T; Trojan J
    Hepatogastroenterology; 2001; 48(39):660-6. PubMed ID: 11462897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the IGF-I antisense strategy in the treatment of the hepatocarcinoma.
    Upegui-Gonzalez LC; Duc HT; Buisson Y; Arborio M; Lafarge-Frayssinet C; Jasmin C; Guo Y; Trojan J
    Adv Exp Med Biol; 1998; 451():35-42. PubMed ID: 10026847
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of insulin-like growth factor-I in rat glioma cells is associated with change in both immunogenicity and apoptosis.
    Ly A; Bouchaud C; Henin D; Sanson M; Delattre JY; Pan Y; Anthony D; Duc HT; Evrard P; Trojan J
    Neurosci Lett; 2000 Mar; 281(1):13-6. PubMed ID: 10686404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I.
    Trojan J; Blossey BK; Johnson TR; Rudin SD; Tykocinski M; Ilan J; Ilan J
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4874-8. PubMed ID: 1594587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
    Liu Y; Wang H; Zhao J; Ma J; Wei L; Wu S; Xie T; Shen F; Trojan J; Habib N; Anthony DD; Wu M; Guo Y
    Cancer Gene Ther; 2000 Mar; 7(3):456-65. PubMed ID: 10766352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of antisense vascular endothelial growth factor RNA on the profile of hepatocellular carcinoma cell line in vitro and in vivo.
    Hao JH; Yu M; Li HK; Shi YR; Li Q; Hao XS
    World J Gastroenterol; 2006 Feb; 12(7):1140-3. PubMed ID: 16534861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hepatoma cell apoptosis by c-myc requires zinc and occurs in the absence of DNA fragmentation.
    Xu J; Xu Y; Nguyen Q; Novikoff PM; Czaja MJ
    Am J Physiol; 1996 Jan; 270(1 Pt 1):G60-70. PubMed ID: 8772502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo.
    Yao M; Wang L; Yang J; Yan X; Cai Y; Yao D
    Tumour Biol; 2016 Nov; 37(11):14677-14686. PubMed ID: 27623941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin-like growth factor I receptor cDNA.
    Du J; Delafontaine P
    Circ Res; 1995 Jun; 76(6):963-72. PubMed ID: 7758167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
    Lamonerie T; Lavialle C; de Galle B; Binoux M; Brison O
    Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-I triple helix gene therapy of rat and human gliomas.
    Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
    Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells.
    Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT
    Cell Physiol Biochem; 2009; 24(3-4):253-62. PubMed ID: 19710540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated anti insulin-like growth factor I gene transfer for the treatment of hepatocellular carcinoma.
    Lafarge-Frayssinet C; Martin C; Van Binh PN; Achard-Ellouk S; Duc HT; Frayssinet C; Cardoso G; Desauty G; Warnet JM; Bréchot C; Sarasin A
    Anticancer Res; 2002; 22(6C):3895-904. PubMed ID: 12553010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I.
    Singh P; Dai B; Dhruva B; Widen SG
    Cancer Res; 1994 Dec; 54(24):6563-70. PubMed ID: 7527300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.
    Burfeind P; Chernicky CL; Rininsland F; Ilan J; Ilan J
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7263-8. PubMed ID: 8692980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.